Home > Balance Sheet > CONCORD DRUGS

CONCORD DRUGS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹0.63 Cr₹0.47 Cr₹0.54 Cr₹0.66 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of CONCORD DRUGS ?

The latest Deferred Tax Assets / Liabilities ratio of CONCORD DRUGS is ₹0.63 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹0.63 Cr
Mar2024₹0.47 Cr
Mar2023₹0.54 Cr
Mar2022₹0.66 Cr

How is Deferred Tax Assets / Liabilities of CONCORD DRUGS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹0.63 Cr
32.35
Mar2024 ₹0.47 Cr
-11.92
Mar2023 ₹0.54 Cr
-18.51
Mar2022 ₹0.66 Cr -

Compare Deferred Tax Assets / Liabilities of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹106.3 Cr 13.4% 16.9% 61% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr NA -3.9% 17.3% Stock Analytics
DIVIS LABORATORIES ₹239,321.0 Cr 5% 21.5% 44.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,924.0 Cr -2.1% -0.2% 34.3% Stock Analytics
CIPLA ₹113,778.0 Cr -2% -2.5% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹99,025.9 Cr 0.4% 4.5% -4.4% Stock Analytics


CONCORD DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

13.4%

16.9%

61%

SENSEX

0.7%

0.8%

-5.1%


You may also like the below Video Courses